Skip to main content
SpringerLink
Log in

Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

The ribonucleotide reductase (RR) gene has been associated with malignant transformation and metastatic potential. In this report, the significance of the expression of RR mRNA and enzymatic activity to the invasive potential was examined by Boyden chamber invasion assay. Our results suggest that overexpression of RR M2 mRNA and RR enzymatic activity correlates to an increase in cell invasive potential. The drug-induced HURs clone expressed a higher level RR M2 mRNA and enzyme activity which contributes significantly to the 3-fold increase in invasive potential of the cells observed relative to the KB wild-type control. On the contrary, the HUr revertant clone decreased the RR M2 mRNA level and enzymatic activity, concomitantly decreasing their invasive potential. This phenomenon is most likely due to the return of RR to levels comparable to that of the KB wild-type cells. To confirm that this observation was not of a drug-resistance phenotype associated with multiple gene alte rations, the panel of RR transfectants (M1-D transfected M1 subunit cDNA, M2-D transfected M2 subunit cDNA, X-D transfected M1/M2 cDNA) characterized in a previous study were also tested in the invasion assay. The M2-D clone expressed 6-fold higher RR M2 mRNA and RR activity and also demonstrated 6-fold higher invasive potential in vitro than either the parental or vector only transfected cell line (KB-V). The X-D clone demonstrated 3-fold higher M2 mRNA expression and revealed 4-fold higher invasive potential than control cells. The M1-D clone, in contrast, expressed a baseline level of RR M2 mRNA and higher M1 mRNA. In contrast to the X-D and M2-D cells, the invasive potential of M1-D reached an even lower level in the invasive assay than the control. These results, therefore, suggest that RR M2 overexpression plays an important role in a tumor's invasiveness. © Rapid Science 1998

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cory JG and Sato A, 1983, Regulation of ribonucleotide reductase activity in mammalian cells. Mol Cell Biochem, 53, 257–66.

    Google Scholar 

  2. Thelander L and Berg P, 1986, Isolation and characterization of expressible cDNA clones encoding the M1 and M2 subunits of mouse ribonucleotide reductase. Mol Cell Biol, 6, 3433–42.

    Google Scholar 

  3. Chang CH and Cheng YC, 1979, Substrate specificity of human ribonucleotide reductase from Molt-4F cells. Cancer Res, 39, 5081–6.

    Google Scholar 

  4. Thelander M, Graslund A and Thelander L, 1985, Subunit M2 of mammalian ribonucleotide reductase. J Biol Chem, 260, 2737–41.

    Google Scholar 

  5. Yen Y, Grill SP, Dutschman GE, Chang CN, Zhou BS and Cheng YC, 1994, Characterization of a hydroxyurea-resistant human KB cell line with supersensitivity to 6-thioguanine. Cancer Res, 54, 3686–91.

    Google Scholar 

  6. Tagger AY and Wright JA, 1988, Molecular and cellular characterization of drug resistant hamster cell lines with alterations in ribonucleotide reductase. Int J Cancer, 42, 760–6.

    Google Scholar 

  7. Albert DA, Nodzenski E, Yim G and Kowalski J, 1990, Effect of cyclic AMP on the cell cycle regulation of ribonucleotide reductase M2 subunit messenger RNA concentrations in wild-type and mutant S49 T lymphoma cells. J Cell Physiol, 143, 251–6.

    Google Scholar 

  8. Engstrom Y, Eriksson S, Jildevik I, Skog S, Thelander L and Tribukait B, 1985, Cell cycle-dependent expression of mammalian ribonucleotide reductase. Differential regulation of the two subunits. J Biol Chem, 260, 9114–6.

    Google Scholar 

  9. Björklund S, Skog S, Tribukait B and Thelander L, 1990, S-phase-specific expression of mammalian ribonucleotide reductase R1 and R2 subunit mRNAs. Biochemistry, 29, 5452–8.

    Google Scholar 

  10. Ali MA, McWeeney D, Milosavljevic A, Jurka J and Jariwalla RJ, 1991, Enhanced malignant transformation induced by expression of a distant protein domain of ribonucleotide reductase large subunit from herpes simplex virus type 2. Proc Nat Acad Sci USA, 88, 8257–61.

    Google Scholar 

  11. Björklund S, Hjortsberg K, Johansson E and Thelander L, 1993, Structure and promoter characterization of the gene encoding the large subunit (R1 protein) of mouse ribonucleotide reductase. Proc Nat Acad Sci USA, 90, 11322–6.

    Google Scholar 

  12. McClarty GA, Chan AKM and Wright JA, 1986, Hydroxyurea-induced conversion of mammalian ribonucleotide reductase to a form hypersensitive to bleomycin. Cancer Res, 46, 4516–21.

    Google Scholar 

  13. Hurta RA, Samuel SK, Greenberg AH and Wright JA, 1991, Early induction of ribonucleotide reductase gene expression by transforming growth factor β-1 in malignant H-ras transformed cell lines. J Biol Chem, 266, 24097–100.

    Google Scholar 

  14. Hurta RA and Wright JA, 1992, Alterations in the activity and regulation of mammalian ribonucleotide reductase by chlorambucil, a DNA damaging agent. J Biol Chem, 267, 7066–71.

    Google Scholar 

  15. Choy BK, McClarty GA and Wright JA, 1989, Transient elevation of ribonucleotide reductase activity, M2 mRNA and M2 protein in BALB/c 3T3 fibroblasts in the presence of 12-O-tetradecanoylphorbol-13-acetate. Biochem Biophys Res Commun, 162, 1417–24.

    Google Scholar 

  16. Mann GJ, Musgrove EA, Fox RM and Thelander L, 1988, Ribonucleotide reductase M1 subunit in cellular proliferation, quiescence, and differentiation. Cancer Res, 48, 5151–6.

    Google Scholar 

  17. Srinivasan PR, Tonin PN, Wensing EJ and Lewis WH, 1987, The gene for ornithine decarboxylase is co-amplified in hydroxyurea-resistant hamster cells. J Biol Chem, 262, 12871–8.

    Google Scholar 

  18. Hurta RAR and Wright JA, 1990, Mammalian drug resistant mutants with multiple gene amplification: genes encoding the M1 component of ribonucleotide reductase, the M2 component of ribonucleotide reductase, ornithine decarboxylase, p5–8, the H-subunit of ferritin and the L-subunit of ferritin. Biochem Biophys Acta, 1087, 165–72.

    Google Scholar 

  19. Luo JA, Smith CC, Kulka M and Aurelian L, 1991, A truncated protein kinase domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) expressed in Escherichia coli. J Biol Chem, 266, 20976–83.

    Google Scholar 

  20. Jones C, Zhu F and Dhanwada KR, 1993, Analysis of a herpes simplex virus 2 fragment from the open reading frame of the large subunit of ribonucleotide reductase with transcriptional regulatory activity. DNA Cell Biol, 12, 127–37.

    Google Scholar 

  21. Desai P, Ramakrishman R, Lin ZW, Osak B, Glorioso JC and Levine M, 1993, The RR gene of herpes simplex virus type 1 is uniquely transactivated by ICPO during infection. J Virol, 67, 6125–35.

    Google Scholar 

  22. Lankinen H, Everett R, Cross A, Conner J and Marsden HS, 1993, Epitope mapping identifies an exposed loop between the unique amino-and conserved carboxy-domains of the large subunit of herpes simplex virus type 1 ribonucleotide reductase. J Gen Virol, 74, 1871–7.

    Google Scholar 

  23. Salem JS, Scott CP, Li LH, Cooperman BS and Rubin H, 1993, High level expression of the large subunit of mouse ribonucleotide reductase in a baculovirus system. FEBS, 323, 93–5.

    Google Scholar 

  24. Howell ML, Sanders-Loehr J, Loehr TM, Roseman NA, Mathews CK and Slabaugh MB, 1992, Cloning of the Vaccinia virus ribonucleotide reductase small subunit gene. J Biol Chem, 267, 1705–11.

    Google Scholar 

  25. Albert DA and Rozengurt E, 1992, Synergistic and coordinate subunits in Swiss 3T3 cells: effect of multiple signal-transduction pathways. Proc Nat Acad USA, 89, 1597–601.

    Google Scholar 

  26. Fan H, Villegas C and Wright JA, 1996, Ribonucleotide reductase R2 component is a novel malignancy determinant that cooperates with activated oncogenes to determine transformation and malignant potential. Proc Natl Acad Sci USA, 93, 14036–40.

    Google Scholar 

  27. Zhou B-S, Hsu N-Y, Pan B-C, Doroshow JH and Yen Y, 1995, Overexpression of ribonucleotide reductase in transfected human KB cells increases their resistance to hydroxyurea: M2 but not M1 is sufficient to increase resistance to hydroxyurea in transfected cells. Cancer Res, 55, 1328–33.

    Google Scholar 

  28. Pavloff N, Rivard D, Masson S, Shen SHH and Mes-Masson AM, 1992, Sequence analysis of the large and small subunits of human RR. DNA Sequence, 2, 227–34.

    Google Scholar 

  29. Wehland J, Schroder HC and Weber K, 1984, Amino acid sequence requirements in the epitope recognized by the tubulin-specific rat monoclonal antibody YL 1/2. EMBO J, 3, 1295–300.

    Google Scholar 

  30. Steeper JP and Stuart CD, 1970, A rapid assay for CDP reductase activity in mammalian cell extracts. Analyt Biochem, 34, 123–30.

    Google Scholar 

  31. Albini A, Iwamoto Y, Kleinman HK, et al. 1987, A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res, 47, 3239–45.

    Google Scholar 

  32. Repesh LA, 1989, A New in vitro assay for quantitating tumor cell invasion. Invasion Metastasis, 9, 192–208.

    Google Scholar 

  33. Mensing H, Pontz BF, Müller PK and Gauss-Müller V, 1983, A study on fibroblast chemotaxis using fibronectin and conditioned medium as chemoattractants. Eur J Cell Biol, 29, 268–73.

    Google Scholar 

  34. Schallreuter KU, Elaren TE, Nelson LS, MacFarlan S, Yan SI and Hogenkamo, HP, 1992, Ribonucleotide diphosphate reductase from human metastatic melanoma. Melanoma Res, 2, 393–400.

    Google Scholar 

  35. Fidler IJ and Hart IR, 1982, Biological diversity in metastatic neoplasms: origin and implications. Science, 217, 998–1003.

    Google Scholar 

  36. Liotta LA, Steeg PS and Stetler-Stevenson WG, 1991, Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64, 327–36.

    Google Scholar 

  37. Wright JA, Egan SE and Greenberg AH, 1990, Genetic regulation of metastatic progression. Anticancer Res, 10, 1247–56.

    Google Scholar 

  38. Steeg PS, 1992, Invasion and metastasis. Curr Opin Oncol, 4, 134–41.

    Google Scholar 

  39. Hart IR and Easty D, 1991, Tumor cell progression and differentiation in metastasis. Seminars Cancer Biol, 2, 87–95.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA

    Bing-Sen Zhou, Pamela Tsai, Rhonda Ker, Jeffrey Tsai, Roger Ho, Johnathan Yu, Jennifer Shih & Yun Yen

Authors
  1. Bing-Sen Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pamela Tsai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rhonda Ker
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jeffrey Tsai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Roger Ho
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Johnathan Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jennifer Shih
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yun Yen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhou, BS., Tsai, P., Ker, R. et al. Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential. Clin Exp Metastasis 16, 43–49 (1998). https://doi.org/10.1023/A:1006559901771

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006559901771

Search

Navigation